High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

byWeizmann Institute of ScienceGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.029The cells that make up cancerous brain tumors are extremely varied and sometimes

Updated on: September 10,2024 0

High-resolution brain tumor mapping reveals possible reason why some patients don't respond to new drug

byWeizmann Institute of ScienceGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.03.029The cells that make up cancerous brain tumors are extremely varied and sometimes

Updated on:September 10,2024 0

Chemo toxicity: A common gene test could save hundreds of lives each year

by Arthur Allen, KFF Health NewsCredit: Unsplash/CC0 Public DomainOne January morning in 2021, Carol Rosen took a standard treatment for metastatic breast cancer. Three gruesome weeks later, she died

Updated on: March 30,2024 0

Chemo toxicity: A common gene test could save hundreds of lives each year

by Arthur Allen, KFF Health NewsCredit: Unsplash/CC0 Public DomainOne January morning in 2021, Carol Rosen took a standard treatment for metastatic breast cancer. Three gruesome weeks later, she died

Updated on:March 30,2024 0

Tumors alone may be linked to cancer patients' cognitive problems

by Emily Caldwell,The Ohio State UniversityCredit: zaldy icaonapo/Public DomainNew research suggests that both tumors and chemotherapy could be linked to the cognitive problems experienced by ca

Updated on: March 12,2024 12

Tumors alone may be linked to cancer patients' cognitive problems

by Emily Caldwell,The Ohio State UniversityCredit: zaldy icaonapo/Public DomainNew research suggests that both tumors and chemotherapy could be linked to the cognitive problems experienced by ca

Updated on:March 12,2024 12

Study identifies new mechanisms that boost p53 signaling and tumor suppression

by Ludwig Cancer ResearchGraphical abstract. Credit:Molecular Cell(2022). DOI: 10.1016/j.molcel.2022.04.010A team led by Ludwig Stanford's Laura Attardi explored novel mechanisms

Updated on: February 01,2024 20

Study identifies new mechanisms that boost p53 signaling and tumor suppression

by Ludwig Cancer ResearchGraphical abstract. Credit:Molecular Cell(2022). DOI: 10.1016/j.molcel.2022.04.010A team led by Ludwig Stanford's Laura Attardi explored novel mechanisms

Updated on:February 01,2024 20

Study confirms new prognostic markers for triple negative breast cancer

by SWOGCredit: CC0 Public DomainPhysicians who treat patients with triple negative breast cancer have two new ways to predict which patients may benefit most from the well-established post-surgery tre

Updated on: March 08,2024 18

Study confirms new prognostic markers for triple negative breast cancer

by SWOGCredit: CC0 Public DomainPhysicians who treat patients with triple negative breast cancer have two new ways to predict which patients may benefit most from the well-established post-surgery tre

Updated on:March 08,2024 18

Some young cancer survivors face higher risk of premature heart failure

by Northwestern UniversityIncident Heart Failure Among YA Cancer Survivors (A) Comparison of history of anthracycline treatment vs none. (B) Stratified by young adult (YA) cancers commonly treate

Updated on: February 03,2024 14

Some young cancer survivors face higher risk of premature heart failure

by Northwestern UniversityIncident Heart Failure Among YA Cancer Survivors (A) Comparison of history of anthracycline treatment vs none. (B) Stratified by young adult (YA) cancers commonly treate

Updated on:February 03,2024 14

Study pinpoints what causes relapse after cancer immunotherapy

by Elaine Fuchs,Rockefeller UniversityKiller T cells surround a cancer cell. Credit: NIHHarnessing the body's immune system to fight off cancer, a tactic known as immunotherapy, has tremendo

Updated on: May 25,2024 7

Study pinpoints what causes relapse after cancer immunotherapy

by Elaine Fuchs,Rockefeller UniversityKiller T cells surround a cancer cell. Credit: NIHHarnessing the body's immune system to fight off cancer, a tactic known as immunotherapy, has tremendo

Updated on:May 25,2024 7

Drug approved to help young patients battle a rare cancer

by Cara Murez HealthDay ReporterChildren and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact.The U.S. Food and Drug Administration has&n

Updated on: February 01,2024 19

Drug approved to help young patients battle a rare cancer

by Cara Murez HealthDay ReporterChildren and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact.The U.S. Food and Drug Administration has&n

Updated on:February 01,2024 19

Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainTreating cancer can sometimes feel like a game of Whac-A-Mole. The disease can become resistant to treatment, and clinicians neve

Updated on: July 05,2024 0

Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainTreating cancer can sometimes feel like a game of Whac-A-Mole. The disease can become resistant to treatment, and clinicians neve

Updated on:July 05,2024 0

Blood cancers: Expert explains what you need to know

by Robin FosterBlood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best to catch them early is essential, one expert says.First, bloo

Updated on: November 10,2024 0

Blood cancers: Expert explains what you need to know

by Robin FosterBlood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best to catch them early is essential, one expert says.First, bloo

Updated on:November 10,2024 0

Autologous stem cell transplant may aid some with nodal PTCL

(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub

Updated on: April 01,2024 17

Autologous stem cell transplant may aid some with nodal PTCL

(HealthDay)—Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study pub

Updated on:April 01,2024 17

Low-cost, portable device can detect colorectal and prostate cancer in an hour

byUniversity of Texas at El PasoA team of researchers from The University of Texas at El Paso, led by Xiujun (James) Li, Ph.D., has created a low-cost, portable device that can detect colorectal

Updated on: November 11,2024 0

Low-cost, portable device can detect colorectal and prostate cancer in an hour

byUniversity of Texas at El PasoA team of researchers from The University of Texas at El Paso, led by Xiujun (James) Li, Ph.D., has created a low-cost, portable device that can detect colorectal

Updated on:November 11,2024 0